MedPath

Delstrigo

Trade Name: Delstrigo

Generic Name: DORAVIRINE,LAMIVUDINE,TENOFOVIR DISOPROXIL

Valid
Registration Number

1612223019

Registration Year

2022

Drug Type

NCE

Legal Status

Prescription

Detailed Information

Comprehensive information about this SFDA approval including dosage forms, packaging, and storage conditions.

Dosage and Strength Information

Film-coated tablet

100mg, 300, 245

Oral use

Tablet Container

Storage and Shelf Life

do not store above 30°c

24 Months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.